NK
Navita Kumari
About Navita Kumari
Data last updated:
Navita Kumari is a Director at Sanmedicare Pharma Private Limited (since 2014) and Director at Euzoe Pharma (Opc) Private Limited (since 2026). The companies operate in Chemicals. The largest current company by reported revenue is Sanmedicare Pharma Private Limited at ₹13.4 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Sep 2014 | 2014 | ₹13.4 Lakh (FY 2019) | Active | |
| Director | 16 Feb 2026 | 2026 | Active |
Board colleagues of Navita Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Ranjan | 06977899 | Sanmedicare Pharma Private Limited | Director |
| Shila Choudhary | 06938781 | Sanmedicare Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navita Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navita Kumari
Navita Kumari currently holds 2 directorships: Sanmedicare Pharma Private Limited (Director, since 10 Sep 2014, revenue ₹13.4 Lakh (FY 2019)); Euzoe Pharma (Opc) Private Limited (Director, since 16 Feb 2026).
Navita Kumari was first appointed on 10 Sep 2014 as Director at Sanmedicare Pharma Private Limited. The most recent appointment on record is 16 Feb 2026 at Euzoe Pharma (Opc) Private Limited.
The current boards of Navita Kumari's companies include Ashish Ranjan (Sanmedicare Pharma Private Limited), Shila Choudhary (Sanmedicare Pharma Private Limited).